Emergent BioSolutions Inc. — Director's Dealing 2023

Oct 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2023-10-03

Reporting Person: DeGolyer Donald W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-03	Common Stock	A	118670	—	Acquired	118670	Direct

Footnotes

F1: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. These restricted stock units will vest in three equal installments over a three-year period assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.